TRANSTHYRETIN AMYLOID CARDIOPATHY
Clinical trials for TRANSTHYRETIN AMYLOID CARDIOPATHY explained in plain language.
Never miss a new study
Get alerted when new TRANSTHYRETIN AMYLOID CARDIOPATHY trials appear
Sign up with your email to follow new studies for TRANSTHYRETIN AMYLOID CARDIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare heart condition: drug aims to stop protein buildup
Disease control TerminatedThis study tests an experimental drug called ION-682884 in people with a rare heart condition caused by abnormal protein deposits (TTR amyloidosis). The drug is designed to lower the production of this protein in the liver, potentially slowing or stopping heart damage. Only patie…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Phase: PHASE2 • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Researchers track real-world treatment of rare heart condition in asia
Knowledge-focused OngoingThis study is a disease registry that collects information from medical records of about 350 adults diagnosed with ATTR-CM, a condition where abnormal protein builds up in the heart. Researchers will look at patient characteristics, treatments, and outcomes as part of usual care—…
Matched conditions: TRANSTHYRETIN AMYLOID CARDIOPATHY
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC